Ali Moinzadeh, MD, is the director of robotic surgery at Lahey Clinic. He is formally trained in the management of urologic cancers and uses the latest surgical techniques with robotic and laparoscopic surgery to minimize patient morbidity. He completed a two-year fellowship in Advanced Robotic and Laparoscopic Surgery at the prestigious Glickman Urologic and Kidney Institute, Cleveland Clinic from 2003 to 2005. As of July 2010, he has performed over 1,000 minimally invasive surgical procedures, including over 550 radical prostatectomies (~500 robotic procedures), kidney, adrenal, ureter, and bladder surgeries. He played an integral part in the development and refinement of techniques for erectile nerve preservation during prostate removal for cancer while working with the world-renowned Inderbir S. Gill at the Cleveland Clinic.

Dr. Moinzadeh received his undergraduate degree with highest distinction from the University of Michigan in Ann Arbor. He earned his medical degree from Northwestern University Medical School in Chicago in 1997. Prior to his current position at Lahey Clinic, Dr. Moinzadeh completed two years of general surgery training at Massachusetts General Hospital, followed by four years of urology residency at Lahey Clinic. After completion of his subspecialty fellowship, he served as chief of robotic and laparoscopic surgery at the State University of New York (SUNY) Upstate Medical Center. At SUNY, he helped establish the robotics program and built one of the busiest minimally invasive urologic cancer programs in upstate New York.

At Lahey Clinic, Dr. Moinzadeh performed the first robotic partial nephrectomy for kidney cancer in 2007 - the first experience in New England - as well as the first robotic radical cystectomy, for bladder cancer, and the first laparoscopic renal tumor cryoablation, for kidney cancer. In 2008, under Dr. Moinzadeh's guidance, Lahey's Institute of Urology acquired one of the world's first surgical robotic simulators to aid in robotic training. Besides the treatment of urologic malignancies, he has one of the highest levels of experience in the world for the treatment of adult ureteral stricture disease using the daVinci® surgical robot. He is one of the few urologists in New England with significant experience in performing retroperitoneal kidney surgery, useful in patients with multiple prior abdominal surgeries.

Dr. Moinzadeh has extensively traveled the United States, proctoring and mentoring other surgeons interested in robotic surgical training in prostatectomy, pyeloplasty, and partial nephrectomy. He has published more than 40 peer-reviewed manuscripts and authored more than 10 book chapters focusing on minimally invasive urologic oncology. He has presented and lectured at numerous scientific meetings. He is a reviewer for several urologic journals and is on the editorial board of the Canadian Journal of Urology. In 2007, he completed the program in clinical effectiveness (epidemiology, biostatistics, and health policy) at Harvard School of Public Health. Current research endeavors include the tracking of surgical data for outcomes reporting.